RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: User Fees

In Focus: User Fees

Posted 01 February 2008

User fees, the monetary charges that the pharmaceutical, biologic and medical device industries pay for review of marketing applications and associated initiatives such as inspections and for manufacturing establishments have been around for some time. This issue of Regulatory Affairs Focus examines the global similarities and differences in how and for what purpose user fees are assessed in various regulatory jurisdictions.


© 2022 Regulatory Affairs Professionals Society.